Literature DB >> 1496826

The pharmacokinetics of propofol in laboratory animals.

I D Cockshott1, E J Douglas, G F Plummer, P J Simons.   

Abstract

1. The pharmacokinetics of propofol in an emulsion formulation ('Diprivan') have been studied after single bolus doses to rats, dogs, rabbits and pigs, and after single and multiple infusions to dogs. Venous blood propofol concentrations were determined by h.p.l.c. with u.v. or fluorescence detection. Curve fitting was performed using ELSFIT. 2. The distribution of propofol in blood and its plasma protein binding have been studied in rat, dog, rabbit and man. Protein binding was high (96-98%), and in most species propofol showed appreciable association with the formed elements of blood. 3. Where an adequate sampling period was employed the pharmacokinetics of propofol were best described by a three-compartment open 'mammillary' model. Propofol was distributed into a large initial volume (1-21/kg) and extensively redistributed (Vss = 2-10 x body weight) in all species. Clearance of propofol by all species was rapid, ranging from about 30-80 ml/kg per min in rats, dogs and pigs to about 340 ml/kg per min in rabbits.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1496826     DOI: 10.3109/00498259209046648

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  10 in total

1.  Anesthetic properties of a propofol microemulsion in dogs.

Authors:  Timothy E Morey; Jerome H Modell; Dushyant Shekhawat; Dinesh O Shah; Brian Klatt; George P Thomas; Frank A Kero; Matthew M Booth; Donn M Dennis
Journal:  Anesth Analg       Date:  2006-10       Impact factor: 5.108

2.  Pharmacokinetics and pharmacodynamics of a new reformulated microemulsion and the long-chain triglyceride emulsion of propofol in beagle dogs.

Authors:  S-H Lee; J-L Ghim; M-H Song; H-G Choi; B-M Choi; H-M Lee; E-K Lee; Y-J Roh; G-J Noh
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

3.  Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol.

Authors:  E H Cox; C A Knibbe; V S Koster; M W Langemeijer; E E Tukker; R Lange; P F Kuks; H J Langemeijer; L Lie-A-Huen; M Danhof
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

4.  Inhibition by propofol of [3H]-batrachotoxinin-A 20-alpha-benzoate binding to voltage-dependent sodium channels in rat cortical synaptosomes.

Authors:  L Ratnakumari; H C Hemmings
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

5.  A novel, lipid-free nanodispersion formulation of propofol and its characterization.

Authors:  Hongming Chen; Zhong Zhang; Orn Almarsson; Jean-Francois Marier; Dina Berkovitz; Colin R Gardner
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

6.  Validation and insights of anesthetic action in an early vertebrate network: the isolated lamprey spinal cord.

Authors:  Steven L Jinks; Jason Andrada
Journal:  Anesth Analg       Date:  2011-07-25       Impact factor: 5.108

7.  Propofol sequestration within the extracorporeal circuit.

Authors:  M Hynynen; E Hammarén; P H Rosenberg
Journal:  Can J Anaesth       Date:  1994-07       Impact factor: 5.063

8.  Cognitive and EEG recovery following bolus intravenous administration of anesthetic agents.

Authors:  S La Marca; R J Lozito; R W Dunn
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

9.  Propofol increases morbidity and mortality in a rat model of sepsis.

Authors:  Martin Schläpfer; Tobias Piegeler; Randal O Dull; David E Schwartz; Mao Mao; Marcelo G Bonini; Birgit Roth Z'Graggen; Beatrice Beck-Schimmer; Richard D Minshall
Journal:  Crit Care       Date:  2015-02-19       Impact factor: 9.097

Review 10.  Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Biomed Res Int       Date:  2018-05-24       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.